Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian A Rowe

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: A prognostic model in patients with alcohol-associated cirrhosis does existVincent Haghnejad, Laura Burke, Siham El Ouahabi, et al.
Hepatology (Baltimore, Md.)|April 22, 2025
Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic reviewVincent Haghnejad, Laura Burke, Siham El Ouahabi, et al.
World Journal of Gastroenterology|October 27, 2010
Retransplantation for graft failure in chronic hepatitis C infection: a good use of a scarce resource?Ian A Rowe, Kerri M Barber, Rhiannon Birch, et al.
Scandinavian Journal of Gastroenterology|June 18, 2025
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control studyHannes Hegmar, Bonnie Bengtsson, Sofia Ullman, et al.
JHEP Reports : Innovation in Hepatology|December 10, 2024
Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysisLaura Burke, Alexander Hinkson, Vincent Haghnejad, et al.
Annals of Hepatology|July 6, 2024
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health recordsIgnat Drozdov, Benjamin Szubert, Ian A Rowe, et al.
Frontline Gastroenterology|July 6, 2023
#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?Kushala Wm Abeysekera, Jessica Shearer, Oliver D Tavabie, et al.
Lancet (London, England)|July 29, 2023
UK liver transplantation allocation algorithm: transplant benefit score - Authors' replyBen M Stutchfield, Antony Attia, Ian A Rowe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 30, 2008
The impact of disease recurrence on graft survival following liver transplantation: a single centre experienceIan A Rowe, Kerry Webb, Bridget K Gunson, et al.
Transplantation|October 13, 2012
HTLV-1 in solid-organ transplantation: current challenges and future management strategiesMatthew J Armstrong, Christopher Corbett, Ian A Rowe, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|September 18, 2025
Reply: A prognostic model in patients with alcohol-associated cirrhosis does existVincent Haghnejad, Laura Burke, Siham El Ouahabi, et al.
Hepatology (Baltimore, Md.)|April 22, 2025
Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic reviewVincent Haghnejad, Laura Burke, Siham El Ouahabi, et al.
World Journal of Gastroenterology|October 27, 2010
Retransplantation for graft failure in chronic hepatitis C infection: a good use of a scarce resource?Ian A Rowe, Kerri M Barber, Rhiannon Birch, et al.
Scandinavian Journal of Gastroenterology|June 18, 2025
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control studyHannes Hegmar, Bonnie Bengtsson, Sofia Ullman, et al.
JHEP Reports : Innovation in Hepatology|December 10, 2024
Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysisLaura Burke, Alexander Hinkson, Vincent Haghnejad, et al.
Annals of Hepatology|July 6, 2024
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health recordsIgnat Drozdov, Benjamin Szubert, Ian A Rowe, et al.
Frontline Gastroenterology|July 6, 2023
#FGDebate: Should we focus on detecting patients at risk of liver disease in the community?Kushala Wm Abeysekera, Jessica Shearer, Oliver D Tavabie, et al.
Lancet (London, England)|July 29, 2023
UK liver transplantation allocation algorithm: transplant benefit score - Authors' replyBen M Stutchfield, Antony Attia, Ian A Rowe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 30, 2008
The impact of disease recurrence on graft survival following liver transplantation: a single centre experienceIan A Rowe, Kerry Webb, Bridget K Gunson, et al.
Transplantation|October 13, 2012
HTLV-1 in solid-organ transplantation: current challenges and future management strategiesMatthew J Armstrong, Christopher Corbett, Ian A Rowe, et al.
Pageof 10